A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease. After over 30 years of research, the trial reprograms ...

The licensed technology was part of the first FDA approved trial to test mesenchymal stem cell derived exosomes in cancer patients. The company's first commercial product, ExoWELL™, is a ...

The company's first commercial product, ExoWELLTM, is a physician-directed, GMP stem cell exosome supplement for application in health and wellness. It has the potential to modulate cellular ...

While the trial focuses on stem cell transplantation, it hints at broader mechanisms—like exosome release—that could transform Parkinson's care by repairing brain damage and enhancing dopamine ...

Say goodbye to hair loss with exosome therapy Explore how exosomes work to stimulate hair follicles and enhance hair density ...

Lately, we've seen ingredients like growth factors and exosomes have a moment in the spotlight, but there's another potent skin-renewal helper that we often forget about: stem cells. According to ...